Agata Sośnicka

Agata Sośnicka

Auto-generated profile, based on publicly available information

Agata Sośnicka

Medical University of Warsaw, Faculty of Pharmacy, Department of Drug Technology and Pharmaceutical Biotechnology, Poland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
MSMuzna Sadia
Muzna Sadia
ASAgata Sośnicka
Agata Sośnicka
BABasel Arafat
Basel Arafat
AIAbdullah Isreb
Abdullah Isreb
WAWaqar Ahmed
Waqar Ahmed
MAMohamed A Alhnan
Mohamed A Alhnan
This work aims to employ fused deposition modelling 3D printing to fabricate immediate release pharmaceutical tablets with several model drugs. It investigates the addition of non-melting filler to methacrylic matrix to facilitate FDM 3D printing and explore the impact of (i) the nature of filler, (ii) compatibility with the gears of the 3D printer and iii) polymer: filler ratio on the 3D printing process. Amongst the investigated fillers in this work, directly compressible lactose, spray-dried lactose and microcrystalline cellulose showed a level of degradation at 135°C whilst talc and TCP allowed consistent flow of the filament and a successful 3D printing of the tablet. A specially developed universal filament based on pharmaceutically approved methacrylic polymer (Eudragit EPO) and thermally stable filler, TCP (tribasic calcium phosphate) was optimised. Four model drugs with different physicochemical properties were included into ready-to-use mechanically stable tablets with immediate release properties. Following the two thermal processes (hot melt extrusion (HME) and fused deposition modelling (FDM) 3D printing), drug contents were 94.22%, 88.53%, 96.51% and 93.04% for 5-ASA, captopril, theophylline and prednisolone respectively. XRPD indicated that a fraction of 5-ASA, theophylline and prednisolone remained crystalline whilst captopril was in amorphous form. By combining the advantages of thermally stable pharmaceutically approved polymers and fillers, this unique approach provides a low cost production method for on demand manufacturing of individualised dosage forms.

14 July 2023 in Chemosphere
Verified
Journal Article
Closed access
BKB. Kózka
B. Kózka
ASA. Sośnicka
A. Sośnicka
GNG. NałęCz-Jawecki
G. NałęCz-Jawecki
ADA. Drobniewska
A. Drobniewska
JTJ. Turło
J. Turło
JGJoanna Giebultowicz
Joanna Giebultowicz